Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • overactive bladder

    Tag: overactive bladder

    You Searched For "overactive bladder"
    Urovant Sciences gets USFDA nod for once-daily 75 mg vibegron for overactive bladder

    Urovant Sciences gets USFDA nod for once-daily 75 mg vibegron for overactive bladder

    Medical Dialogues Bureau9 March 2020 12:26 PM IST
    IRVINE -Urovant Sciences has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application...
    Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder

    Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder

    Medical Dialogues Bureau28 Sept 2019 2:38 PM IST
    "Solifenacin Succinate Tablet is a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US, Inc, " Strides Pharma said.Bangalore:...
    Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

    Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

    Farhat Nasim28 Jun 2019 11:10 AM IST
    The approval by the US Food and Drug Administration (USFDA) is for a generic version of Mirabegron ER tablets of strengths 25 mg and 50 mg, Lupin said...
    Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder

    Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder

    Farhat Nasim2 April 2019 11:50 AM IST
    The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release...
    Zydus gets USFDA nod for overactive bladder drug

    Zydus gets USFDA nod for overactive bladder drug

    Ruby Khatun Khatun6 Oct 2017 9:49 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market capsules used in treating overactive...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok